Management of Subconjunctival Hemorrhage in Patients Taking Clopidogrel
No specific therapy is required for subconjunctival hemorrhage in patients taking clopidogrel—continue the antiplatelet medication and provide supportive care with artificial tears only. 1, 2
Clinical Approach
Do not discontinue clopidogrel for subconjunctival hemorrhage. This is a benign, self-limited condition that does not warrant interruption of antiplatelet therapy, which would expose the patient to catastrophic thrombotic risks including stent thrombosis, myocardial infarction, and death. 3, 4
Supportive Management Only
- Reassure the patient that subconjunctival hemorrhage is benign and will resolve spontaneously within 1-2 weeks 1
- Prescribe artificial tears for symptomatic relief if needed 2
- Continue clopidogrel without interruption 3
Risk Assessment for Underlying Pathology
While the hemorrhage itself requires no treatment, evaluate for conditions that may have precipitated it:
- Check blood pressure at the visit, as systemic hypertension is a major risk factor in elderly patients 1
- Review for recent trauma or contact lens use, which are common precipitants 1
- If recurrent or bilateral, consider workup for bleeding disorders, though this is rare 1, 2
Critical Safety Considerations
Never stop clopidogrel without cardiology consultation in patients with coronary stents. The evidence is unequivocal:
- Discontinuation of antiplatelet therapy carries a hazard ratio of 161 for death and MI 5
- Stent thrombosis risk increases after just 5 days without therapy and carries a 40% risk of MI or death 5
- Patients with drug-eluting stents placed within 12 months or bare-metal stents within 1 month face the highest thrombotic risk 3, 4
When to Escalate Care
Subconjunctival hemorrhage does not require ophthalmology referral unless:
- Massive choroidal hemorrhage develops (extremely rare, presents with severe pain, vision loss, and angle closure—not simple subconjunctival hemorrhage) 6
- Vision is affected (suggests a different diagnosis entirely)
- Recurrent episodes warrant evaluation for systemic bleeding disorders 1
Common Pitfall to Avoid
The most dangerous error is stopping clopidogrel unnecessarily. Subconjunctival hemorrhage is a cosmetic issue with zero functional consequence that resolves spontaneously, whereas premature clopidogrel discontinuation can be immediately fatal. 5, 3, 4